nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—hypertension—chronic kidney failure	0.678	1	CtDrD
Valsartan—ALB—chronic kidney failure	0.213	1	CbGaD
Valsartan—CYP2C9—cardial valve—chronic kidney failure	0.00817	0.263	CbGeAlD
Valsartan—AGTR1—nephron—chronic kidney failure	0.00456	0.147	CbGeAlD
Valsartan—AGTR1—artery—chronic kidney failure	0.00254	0.082	CbGeAlD
Valsartan—AGTR1—blood plasma—chronic kidney failure	0.00191	0.0616	CbGeAlD
Valsartan—SLCO1B1—blood plasma—chronic kidney failure	0.00182	0.0587	CbGeAlD
Valsartan—CYP2C9—urine—chronic kidney failure	0.00176	0.0568	CbGeAlD
Valsartan—AGTR1—nephron tubule—chronic kidney failure	0.000985	0.0317	CbGeAlD
Valsartan—CYP2C9—blood plasma—chronic kidney failure	0.000919	0.0296	CbGeAlD
Valsartan—AGTR1—renal system—chronic kidney failure	0.000895	0.0289	CbGeAlD
Valsartan—AGTR1—cardiovascular system—chronic kidney failure	0.000884	0.0285	CbGeAlD
Valsartan—AGTR1—kidney—chronic kidney failure	0.000865	0.0279	CbGeAlD
Valsartan—SLCO1B1—renal system—chronic kidney failure	0.000853	0.0275	CbGeAlD
Valsartan—AGTR1—cortex of kidney—chronic kidney failure	0.000843	0.0272	CbGeAlD
Valsartan—SLCO1B1—kidney—chronic kidney failure	0.000825	0.0266	CbGeAlD
Valsartan—Olmesartan—ABCC2—chronic kidney failure	0.000757	0.211	CrCbGaD
Valsartan—SLCO1B1—digestive system—chronic kidney failure	0.0007	0.0226	CbGeAlD
Valsartan—AGTR1—blood—chronic kidney failure	0.000699	0.0225	CbGeAlD
Valsartan—SLCO1B1—blood—chronic kidney failure	0.000667	0.0215	CbGeAlD
Valsartan—Irbesartan—PTGS1—chronic kidney failure	0.000446	0.124	CrCbGaD
Valsartan—Candesartan—PTGS1—chronic kidney failure	0.000446	0.124	CrCbGaD
Valsartan—CYP2C9—cardiovascular system—chronic kidney failure	0.000426	0.0137	CbGeAlD
Valsartan—Tasosartan—CYP3A4—chronic kidney failure	0.000396	0.11	CrCbGaD
Valsartan—Losartan—ACE—chronic kidney failure	0.000357	0.0993	CrCbGaD
Valsartan—CYP2C9—digestive system—chronic kidney failure	0.000354	0.0114	CbGeAlD
Valsartan—CYP2C9—blood—chronic kidney failure	0.000337	0.0109	CbGeAlD
Valsartan—Losartan—CYP2C19—chronic kidney failure	0.000264	0.0733	CrCbGaD
Valsartan—Irbesartan—CYP3A4—chronic kidney failure	0.00026	0.0724	CrCbGaD
Valsartan—Candesartan—ABCB1—chronic kidney failure	0.000217	0.0602	CrCbGaD
Valsartan—Losartan—CYP3A4—chronic kidney failure	0.000168	0.0466	CrCbGaD
Valsartan—Losartan—ALB—chronic kidney failure	0.000146	0.0407	CrCbGaD
Valsartan—Losartan—ABCB1—chronic kidney failure	0.00014	0.0388	CrCbGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic kidney failure	3.45e-05	0.000465	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ARG2—chronic kidney failure	3.45e-05	0.000465	CbGpPWpGaD
Valsartan—CYP2C9—Metapathway biotransformation—CYP1A1—chronic kidney failure	3.45e-05	0.000464	CbGpPWpGaD
Valsartan—ALB—SLC-mediated transmembrane transport—AVP—chronic kidney failure	3.44e-05	0.000463	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	3.43e-05	0.000461	CbGpPWpGaD
Valsartan—ALB—Platelet degranulation—TGFB1—chronic kidney failure	3.39e-05	0.000456	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—LCAT—chronic kidney failure	3.39e-05	0.000456	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	3.36e-05	0.000452	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—GCKR—chronic kidney failure	3.33e-05	0.000448	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—ABCC3—chronic kidney failure	3.33e-05	0.000448	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CPT1A—chronic kidney failure	3.31e-05	0.000446	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—EDN1—chronic kidney failure	3.29e-05	0.000443	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—FGF23—chronic kidney failure	3.29e-05	0.000442	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CCL5—chronic kidney failure	3.27e-05	0.00044	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CCR5—chronic kidney failure	3.24e-05	0.000436	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—LIPC—chronic kidney failure	3.23e-05	0.000434	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CYP2C19—chronic kidney failure	3.23e-05	0.000434	CbGpPWpGaD
Valsartan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic kidney failure	3.23e-05	0.000434	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—ABCC2—chronic kidney failure	3.19e-05	0.00043	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	3.18e-05	0.000429	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PRKD1—chronic kidney failure	3.17e-05	0.000427	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PRKAG2—chronic kidney failure	3.17e-05	0.000427	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—DDC—chronic kidney failure	3.11e-05	0.000418	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NPY—chronic kidney failure	3.09e-05	0.000416	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—AVP—chronic kidney failure	3.06e-05	0.000412	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PRKD1—chronic kidney failure	3.02e-05	0.000406	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PRKAG2—chronic kidney failure	3.02e-05	0.000406	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CYP2B6—chronic kidney failure	3.02e-05	0.000406	CbGpPWpGaD
Valsartan—ALB—Metabolism—FABP1—chronic kidney failure	3e-05	0.000404	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CRH—chronic kidney failure	2.98e-05	0.000402	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—OXT—chronic kidney failure	2.98e-05	0.000402	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—SCARB1—chronic kidney failure	2.98e-05	0.000401	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL6—chronic kidney failure	2.98e-05	0.000401	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	2.97e-05	0.0004	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	2.97e-05	0.000399	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	2.96e-05	0.000399	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PTGS1—chronic kidney failure	2.95e-05	0.000397	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CCR5—chronic kidney failure	2.94e-05	0.000396	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—TNF—chronic kidney failure	2.93e-05	0.000394	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	2.9e-05	0.000391	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—SREBF1—chronic kidney failure	2.89e-05	0.00039	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	2.87e-05	0.000386	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	2.87e-05	0.000386	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—F2—chronic kidney failure	2.86e-05	0.000385	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NCF1—chronic kidney failure	2.86e-05	0.000385	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	2.85e-05	0.000384	CbGpPWpGaD
Valsartan—ALB—Metabolism—GATM—chronic kidney failure	2.85e-05	0.000383	CbGpPWpGaD
Valsartan—ALB—Metabolism—AGXT—chronic kidney failure	2.85e-05	0.000383	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NPS—chronic kidney failure	2.83e-05	0.000381	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—SREBF2—chronic kidney failure	2.83e-05	0.00038	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—HMGCR—chronic kidney failure	2.82e-05	0.000379	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	2.8e-05	0.000377	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	2.78e-05	0.000374	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	2.78e-05	0.000374	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—F2—chronic kidney failure	2.78e-05	0.000374	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—DRD1—chronic kidney failure	2.77e-05	0.000373	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—ALB—chronic kidney failure	2.76e-05	0.000372	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—FASN—chronic kidney failure	2.76e-05	0.000371	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	2.75e-05	0.00037	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ABCC3—chronic kidney failure	2.73e-05	0.000367	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GCKR—chronic kidney failure	2.73e-05	0.000367	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CYBA—chronic kidney failure	2.69e-05	0.000362	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—LPIN1—chronic kidney failure	2.67e-05	0.000359	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	2.62e-05	0.000353	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CYP2C18—chronic kidney failure	2.62e-05	0.000352	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—LRP2—chronic kidney failure	2.62e-05	0.000352	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—POMC—chronic kidney failure	2.61e-05	0.000351	CbGpPWpGaD
Valsartan—ALB—Metabolism—ACAT1—chronic kidney failure	2.6e-05	0.00035	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	2.57e-05	0.000346	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CYP3A4—chronic kidney failure	2.55e-05	0.000344	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	2.54e-05	0.000342	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	2.54e-05	0.000342	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—POMC—chronic kidney failure	2.53e-05	0.000341	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—F2—chronic kidney failure	2.53e-05	0.00034	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ABCA1—chronic kidney failure	2.51e-05	0.000338	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—IGF1—chronic kidney failure	2.51e-05	0.000337	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—PPARA—chronic kidney failure	2.5e-05	0.000336	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	2.49e-05	0.000336	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—FABP1—chronic kidney failure	2.46e-05	0.000331	CbGpPWpGaD
Valsartan—ALB—Hemostasis—NOS1—chronic kidney failure	2.44e-05	0.000329	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	2.43e-05	0.000327	CbGpPWpGaD
Valsartan—ALB—Metabolism—MLXIPL—chronic kidney failure	2.42e-05	0.000326	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic kidney failure	2.38e-05	0.00032	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	2.37e-05	0.00032	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—IL6—chronic kidney failure	2.36e-05	0.000318	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HBEGF—chronic kidney failure	2.36e-05	0.000317	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	2.34e-05	0.000314	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—AGXT—chronic kidney failure	2.33e-05	0.000314	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GATM—chronic kidney failure	2.33e-05	0.000314	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—POMC—chronic kidney failure	2.3e-05	0.00031	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	2.28e-05	0.000306	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	2.28e-05	0.000306	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CCL2—chronic kidney failure	2.25e-05	0.000303	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CPT1A—chronic kidney failure	2.22e-05	0.000299	CbGpPWpGaD
Valsartan—ALB—Metabolism—SLC22A2—chronic kidney failure	2.21e-05	0.000298	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—LIPC—chronic kidney failure	2.17e-05	0.000292	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CYP2C19—chronic kidney failure	2.17e-05	0.000292	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	2.16e-05	0.000291	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	2.14e-05	0.000288	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ACAT1—chronic kidney failure	2.13e-05	0.000287	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CAT—chronic kidney failure	2.12e-05	0.000286	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	2.1e-05	0.000283	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	2.08e-05	0.00028	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ABCB1—chronic kidney failure	2.07e-05	0.000278	CbGpPWpGaD
Valsartan—ALB—Metabolism—ABCG1—chronic kidney failure	2.06e-05	0.000277	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—AVP—chronic kidney failure	2.04e-05	0.000275	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	2.04e-05	0.000275	CbGpPWpGaD
Valsartan—ALB—Metabolism—PIP5K1B—chronic kidney failure	2.01e-05	0.000271	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—SCARB1—chronic kidney failure	2e-05	0.00027	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	1.99e-05	0.000267	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PTGS1—chronic kidney failure	1.98e-05	0.000267	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MLXIPL—chronic kidney failure	1.98e-05	0.000267	CbGpPWpGaD
Valsartan—ALB—Metabolism—ARG2—chronic kidney failure	1.97e-05	0.000266	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—LPL—chronic kidney failure	1.97e-05	0.000265	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	1.95e-05	0.000263	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—EDN1—chronic kidney failure	1.94e-05	0.000262	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—SREBF1—chronic kidney failure	1.94e-05	0.000262	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	1.94e-05	0.000262	CbGpPWpGaD
Valsartan—ALB—Metabolism—LCAT—chronic kidney failure	1.93e-05	0.00026	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCL5—chronic kidney failure	1.93e-05	0.00026	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CYP1A1—chronic kidney failure	1.9e-05	0.000256	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—HMGCR—chronic kidney failure	1.89e-05	0.000255	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—LPL—chronic kidney failure	1.89e-05	0.000254	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic kidney failure	1.85e-05	0.00025	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—FASN—chronic kidney failure	1.85e-05	0.000249	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—SLC22A2—chronic kidney failure	1.81e-05	0.000244	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NGF—chronic kidney failure	1.79e-05	0.000241	CbGpPWpGaD
Valsartan—ALB—Metabolism—DDC—chronic kidney failure	1.78e-05	0.000239	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—MTHFR—chronic kidney failure	1.77e-05	0.000239	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	1.77e-05	0.000238	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—AVP—chronic kidney failure	1.75e-05	0.000235	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PPARA—chronic kidney failure	1.74e-05	0.000234	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCR5—chronic kidney failure	1.74e-05	0.000234	CbGpPWpGaD
Valsartan—ALB—Metabolism—PRKD1—chronic kidney failure	1.72e-05	0.000232	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP2B6—chronic kidney failure	1.72e-05	0.000232	CbGpPWpGaD
Valsartan—ALB—Metabolism—PRKAG2—chronic kidney failure	1.72e-05	0.000232	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CYP3A4—chronic kidney failure	1.71e-05	0.000231	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	1.71e-05	0.00023	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	1.7e-05	0.000228	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	1.69e-05	0.000228	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ABCA1—chronic kidney failure	1.69e-05	0.000227	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ABCG1—chronic kidney failure	1.68e-05	0.000227	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PIP5K1B—chronic kidney failure	1.65e-05	0.000222	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	1.64e-05	0.000221	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic kidney failure	1.64e-05	0.00022	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ARG2—chronic kidney failure	1.61e-05	0.000217	CbGpPWpGaD
Valsartan—ALB—Metabolism—SREBF2—chronic kidney failure	1.61e-05	0.000217	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PLAU—chronic kidney failure	1.59e-05	0.000213	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—LCAT—chronic kidney failure	1.58e-05	0.000213	CbGpPWpGaD
Valsartan—ALB—Metabolism—GCKR—chronic kidney failure	1.56e-05	0.00021	CbGpPWpGaD
Valsartan—ALB—Metabolism—ABCC3—chronic kidney failure	1.56e-05	0.00021	CbGpPWpGaD
Valsartan—ALB—Metabolism—LPIN1—chronic kidney failure	1.53e-05	0.000205	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic kidney failure	1.5e-05	0.000202	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	1.5e-05	0.000202	CbGpPWpGaD
Valsartan—ALB—Metabolism—LRP2—chronic kidney failure	1.49e-05	0.000201	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP2C18—chronic kidney failure	1.49e-05	0.000201	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—F2—chronic kidney failure	1.49e-05	0.000201	CbGpPWpGaD
Valsartan—ALB—Hemostasis—F2—chronic kidney failure	1.47e-05	0.000198	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—DDC—chronic kidney failure	1.45e-05	0.000196	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CAT—chronic kidney failure	1.43e-05	0.000192	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—PPARA—chronic kidney failure	1.43e-05	0.000192	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—POMC—chronic kidney failure	1.42e-05	0.000191	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PRKAG2—chronic kidney failure	1.41e-05	0.00019	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP2B6—chronic kidney failure	1.41e-05	0.00019	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PRKD1—chronic kidney failure	1.41e-05	0.00019	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IRS1—chronic kidney failure	1.41e-05	0.00019	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	1.39e-05	0.000187	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ABCB1—chronic kidney failure	1.39e-05	0.000187	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—POMC—chronic kidney failure	1.36e-05	0.000183	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	1.34e-05	0.000181	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCL2—chronic kidney failure	1.33e-05	0.000179	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—LPL—chronic kidney failure	1.32e-05	0.000178	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—SREBF2—chronic kidney failure	1.32e-05	0.000178	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IGF1—chronic kidney failure	1.31e-05	0.000176	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ALB—chronic kidney failure	1.29e-05	0.000174	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IGF1—chronic kidney failure	1.29e-05	0.000174	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CYP1A1—chronic kidney failure	1.28e-05	0.000172	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GCKR—chronic kidney failure	1.28e-05	0.000172	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ABCC3—chronic kidney failure	1.28e-05	0.000172	CbGpPWpGaD
Valsartan—ALB—Metabolism—CPT1A—chronic kidney failure	1.27e-05	0.000171	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—LPIN1—chronic kidney failure	1.25e-05	0.000168	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—SERPINE1—chronic kidney failure	1.24e-05	0.000167	CbGpPWpGaD
Valsartan—ALB—Metabolism—LIPC—chronic kidney failure	1.24e-05	0.000167	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP2C19—chronic kidney failure	1.24e-05	0.000167	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—NOS3—chronic kidney failure	1.24e-05	0.000166	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—KRAS—chronic kidney failure	1.23e-05	0.000165	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	1.23e-05	0.000165	CbGpPWpGaD
Valsartan—ALB—Hemostasis—SERPINE1—chronic kidney failure	1.23e-05	0.000165	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP2C18—chronic kidney failure	1.22e-05	0.000165	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—LRP2—chronic kidney failure	1.22e-05	0.000165	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	1.22e-05	0.000165	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MTHFR—chronic kidney failure	1.19e-05	0.00016	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NOS3—chronic kidney failure	1.18e-05	0.00016	CbGpPWpGaD
Valsartan—ALB—Hemostasis—NOS3—chronic kidney failure	1.17e-05	0.000158	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PPARA—chronic kidney failure	1.17e-05	0.000157	CbGpPWpGaD
Valsartan—ALB—Metabolism—SCARB1—chronic kidney failure	1.14e-05	0.000154	CbGpPWpGaD
Valsartan—ALB—Metabolism—PTGS1—chronic kidney failure	1.13e-05	0.000152	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PTGS2—chronic kidney failure	1.13e-05	0.000152	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—RELA—chronic kidney failure	1.12e-05	0.00015	CbGpPWpGaD
Valsartan—ALB—Metabolism—SREBF1—chronic kidney failure	1.11e-05	0.00015	CbGpPWpGaD
Valsartan—ALB—Metabolism—HMGCR—chronic kidney failure	1.08e-05	0.000145	CbGpPWpGaD
Valsartan—ALB—Metabolism—FASN—chronic kidney failure	1.06e-05	0.000142	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CPT1A—chronic kidney failure	1.04e-05	0.00014	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—LIPC—chronic kidney failure	1.01e-05	0.000136	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP2C19—chronic kidney failure	1.01e-05	0.000136	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	1e-05	0.000135	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL6—chronic kidney failure	1e-05	0.000135	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP3A4—chronic kidney failure	9.8e-06	0.000132	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	9.75e-06	0.000131	CbGpPWpGaD
Valsartan—ALB—Metabolism—ABCA1—chronic kidney failure	9.63e-06	0.00013	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—POMC—chronic kidney failure	9.53e-06	0.000128	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NFKB1—chronic kidney failure	9.41e-06	0.000127	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—SCARB1—chronic kidney failure	9.37e-06	0.000126	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PTGS1—chronic kidney failure	9.27e-06	0.000125	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	9.12e-06	0.000123	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—SREBF1—chronic kidney failure	9.09e-06	0.000122	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—HMGCR—chronic kidney failure	8.85e-06	0.000119	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ALB—chronic kidney failure	8.69e-06	0.000117	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—FASN—chronic kidney failure	8.66e-06	0.000117	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—VEGFA—chronic kidney failure	8.54e-06	0.000115	CbGpPWpGaD
Valsartan—ALB—Hemostasis—VEGFA—chronic kidney failure	8.43e-06	0.000114	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—NOS3—chronic kidney failure	8.31e-06	0.000112	CbGpPWpGaD
Valsartan—ALB—Metabolism—CAT—chronic kidney failure	8.15e-06	0.00011	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP3A4—chronic kidney failure	8.02e-06	0.000108	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	7.98e-06	0.000107	CbGpPWpGaD
Valsartan—ALB—Metabolism—ABCB1—chronic kidney failure	7.93e-06	0.000107	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ABCA1—chronic kidney failure	7.89e-06	0.000106	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TGFB1—chronic kidney failure	7.84e-06	0.000105	CbGpPWpGaD
Valsartan—ALB—Hemostasis—TGFB1—chronic kidney failure	7.74e-06	0.000104	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PTGS2—chronic kidney failure	7.6e-06	0.000102	CbGpPWpGaD
Valsartan—ALB—Metabolism—LPL—chronic kidney failure	7.56e-06	0.000102	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP1A1—chronic kidney failure	7.3e-06	9.83e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—KRAS—chronic kidney failure	7.26e-06	9.77e-05	CbGpPWpGaD
Valsartan—ALB—Hemostasis—KRAS—chronic kidney failure	7.17e-06	9.65e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—MTHFR—chronic kidney failure	6.81e-06	9.16e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—PPARA—chronic kidney failure	6.68e-06	8.99e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CAT—chronic kidney failure	6.67e-06	8.98e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ABCB1—chronic kidney failure	6.49e-06	8.74e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—LPL—chronic kidney failure	6.19e-06	8.33e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP1A1—chronic kidney failure	5.98e-06	8.04e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL6—chronic kidney failure	5.9e-06	7.95e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MTHFR—chronic kidney failure	5.57e-06	7.5e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PPARA—chronic kidney failure	5.47e-06	7.36e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—POMC—chronic kidney failure	5.44e-06	7.33e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—NOS3—chronic kidney failure	4.75e-06	6.39e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—POMC—chronic kidney failure	4.46e-06	6e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—PTGS2—chronic kidney failure	4.34e-06	5.84e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALB—chronic kidney failure	4.06e-06	5.47e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—NOS3—chronic kidney failure	3.89e-06	5.23e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PTGS2—chronic kidney failure	3.55e-06	4.78e-05	CbGpPWpGaD
